Concepedia

Sequential Intravesical Gemcitabine and Docetaxel is an Alternative to Bacillus Calmette-Guérin for the Treatment of Intermediate-risk Non–muscle-invasive Bladder Cancer

Wei Shen Tan, Ian M. McElree, Facundo Davaro, Ryan L. Steinberg, Kelly K. Bree, Neema Navai, Colin P. Dinney, Michael A. O’Donnell, Roger Li, Ashish M. Kamat,

European Urology Oncology · 2023 · 36 citations · 6 references

DOI

Concepts

References

6

Multi-Institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy for Nonmuscle Invasive Bladder Cancer

Ryan L. Steinberg, Lewis J. Thomas, Nathan A. Brooks et al. · The Journal of Urology · 2019 · 182 citations

, , +5

Bacillus Calmette-Guérin With or Without Interferon α-2b and Megadose Versus Recommended Daily Allowance Vitamins During Induction and Maintenance Intravesical Treatment of Nonmuscle Invasive Bladder Cancer

Kenneth G. Nepple, Andrew J. Lightfoot, Henry Rosevear et al. · The Journal of Urology · 2010 · 122 citations

, , +8

Comparison of Sequential Intravesical Gemcitabine and Docetaxel vs Bacillus Calmette-Guérin for the Treatment of Patients With High-Risk Non–Muscle-Invasive Bladder Cancer

Ian M. McElree, Ryan L. Steinberg, Sarah L. Mott et al. · JAMA Network Open · 2023 · 113 citations · Full text

, , +9

Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non–muscle-invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Controlled Trial

Wei Shen Tan, Aaron Prendergast, Charlotte Ackerman et al. · European Urology · 2022 · 59 citations · Full text

, , +16

Hyperthermic Mitomycin C in Intermediate-risk Non–muscle-invasive Bladder Cancer: Results of the HIVEC-1 Trial

J.C. Angulo, J.L. Álvarez-Ossorio, José L. Domínguez-Escrig et al. · European Urology Oncology · 2022 · 39 citations

, , +12